| Hijinio G Carreon, DO | |
|
1111 6th Ave, Emergency Department, Des Moines, IA 50314-2610 | |
| (515) 247-4445 | |
| Not Available |
| Full Name | Hijinio G Carreon |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 21 Years |
| Location | 1111 6th Ave, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033122072 | NPI | - | NPPES |
| 036114525 | Medicaid | IL | |
| 800810 | Other | MEDICARE GROUP NO. |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | DO-03811 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Des Moines River Physicians Llc | 0143549634 | 43 |
News Archive
Aeterna Zentaris Inc. today announced that Johanna Bendell, MD, Director of Gastrointestinal Cancer Research and Associate Director of Drug Development at the Sarah Cannon Research Institute in Nashville, Tennessee, presented Phase 3 results for perifosine in refractory colorectal cancer yesterday, at the American Society of Clinical Oncology (ASCO) Annual Meeting which is being held in Chicago.
Men treated with radiotherapy as well as hormone therapy for advanced prostate cancer were 43 per cent less likely to die from the disease, according to trial results presented at the NCRI Cancer Conference in Liverpool today (Monday).
Physicians at Rush University Medical Center are testing a unique gene therapy product called CERE-120 to evaluate if its use can improve the symptoms of Parkinson's disease. Rush is one of 11 sites in the U.S. and the only site in Illinois enrolling patients into the new, double-blinded trial.
The Department of Nuclear Medicine at the Frankfurt University Hospital recently became the first European hospital to use microwaves to ablate thyroid nodules.
› Verified 1 days ago
| Entity Name | Des Moines River Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720472442 PECOS PAC ID: 0143549634 Enrollment ID: O20150505001794 |
News Archive
Aeterna Zentaris Inc. today announced that Johanna Bendell, MD, Director of Gastrointestinal Cancer Research and Associate Director of Drug Development at the Sarah Cannon Research Institute in Nashville, Tennessee, presented Phase 3 results for perifosine in refractory colorectal cancer yesterday, at the American Society of Clinical Oncology (ASCO) Annual Meeting which is being held in Chicago.
Men treated with radiotherapy as well as hormone therapy for advanced prostate cancer were 43 per cent less likely to die from the disease, according to trial results presented at the NCRI Cancer Conference in Liverpool today (Monday).
Physicians at Rush University Medical Center are testing a unique gene therapy product called CERE-120 to evaluate if its use can improve the symptoms of Parkinson's disease. Rush is one of 11 sites in the U.S. and the only site in Illinois enrolling patients into the new, double-blinded trial.
The Department of Nuclear Medicine at the Frankfurt University Hospital recently became the first European hospital to use microwaves to ablate thyroid nodules.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hijinio G Carreon, DO Po Box 4925, Des Moines, IA 50306-4925 Ph: (515) 643-4973 | Hijinio G Carreon, DO 1111 6th Ave, Emergency Department, Des Moines, IA 50314-2610 Ph: (515) 247-4445 |
News Archive
Aeterna Zentaris Inc. today announced that Johanna Bendell, MD, Director of Gastrointestinal Cancer Research and Associate Director of Drug Development at the Sarah Cannon Research Institute in Nashville, Tennessee, presented Phase 3 results for perifosine in refractory colorectal cancer yesterday, at the American Society of Clinical Oncology (ASCO) Annual Meeting which is being held in Chicago.
Men treated with radiotherapy as well as hormone therapy for advanced prostate cancer were 43 per cent less likely to die from the disease, according to trial results presented at the NCRI Cancer Conference in Liverpool today (Monday).
Physicians at Rush University Medical Center are testing a unique gene therapy product called CERE-120 to evaluate if its use can improve the symptoms of Parkinson's disease. Rush is one of 11 sites in the U.S. and the only site in Illinois enrolling patients into the new, double-blinded trial.
The Department of Nuclear Medicine at the Frankfurt University Hospital recently became the first European hospital to use microwaves to ablate thyroid nodules.
› Verified 1 days ago
Myles Kawamura, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Emergency Department, Des Moines, IA 50314 Phone: 515-247-3211 Fax: 515-643-8933 | |
Brooke Johnson, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-6262 | |
Dr. Chad William Becker, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-6412 | |
Dr. Kevin Pothoven, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-247-3211 Fax: 515-643-8722 | |
Dr. Anastasia Maria Marx, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-6212 | |
Dr. Benjamin R Sweet, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-247-3121 |